AT264715B - Verfahren zur Herstellung von Tabletten mit protrahierter Wirkung - Google Patents

Verfahren zur Herstellung von Tabletten mit protrahierter Wirkung

Info

Publication number
AT264715B
AT264715B AT802665A AT802665A AT264715B AT 264715 B AT264715 B AT 264715B AT 802665 A AT802665 A AT 802665A AT 802665 A AT802665 A AT 802665A AT 264715 B AT264715 B AT 264715B
Authority
AT
Austria
Prior art keywords
tablets
manufacture
extended action
extended
action
Prior art date
Application number
AT802665A
Other languages
English (en)
Inventor
Aldo Dr Riva
Original Assignee
Wander Ag Dr A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wander Ag Dr A filed Critical Wander Ag Dr A
Application granted granted Critical
Publication of AT264715B publication Critical patent/AT264715B/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
AT802665A 1964-09-04 1965-09-01 Verfahren zur Herstellung von Tabletten mit protrahierter Wirkung AT264715B (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH1156164A CH415963A (de) 1964-09-04 1964-09-04 Masse zur Herstellung von Tabletten mit protrahierter Wirkung

Publications (1)

Publication Number Publication Date
AT264715B true AT264715B (de) 1968-09-10

Family

ID=4374676

Family Applications (1)

Application Number Title Priority Date Filing Date
AT802665A AT264715B (de) 1964-09-04 1965-09-01 Verfahren zur Herstellung von Tabletten mit protrahierter Wirkung

Country Status (7)

Country Link
US (1) US3459850A (de)
AT (1) AT264715B (de)
BR (1) BR6572781D0 (de)
CH (1) CH415963A (de)
DE (1) DE1492253A1 (de)
FR (1) FR4892M (de)
GB (1) GB1112332A (de)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0120118A1 (de) * 1983-01-03 1984-10-03 Verex Laboratories, Inc. Feste orale Dosierungsformulierungen von kardiovaskularen Heilmitteln mit konstanter Freisetzungsgeschwindigkeit
EP0095123A3 (en) * 1982-05-20 1984-12-12 Merrell Dow Pharmaceuticals Inc. Sustained release diethylpropion compositions

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1456365A (en) * 1972-10-06 1976-11-24 Gist Brocades Nv Controlled release composition
FI63335B (fi) * 1979-02-02 1983-02-28 Orion Yhtymae Oy Foerfarande foer framstaellning av tabletter med foerdroejd loslighet av effektaemne
FR2549371B1 (fr) * 1983-07-20 1985-09-13 Sanofi Sa Nouvelle composition pharmaceutique contenant de l'acide valproique ou un de ses sels
JPH0816066B2 (ja) * 1986-07-18 1996-02-21 エーザイ株式会社 持続性薬効製剤
WO1989002742A1 (en) * 1987-10-05 1989-04-06 Pharmagyn, Inc. Tablet for use in the treatment of progesterone deficiency
DE19600324A1 (de) * 1996-01-08 1997-07-10 Basf Ag Granulate für kosmetische und pharmazeutische Zubereitungen
AU2002221412B2 (en) 2000-12-05 2006-04-13 Alexander Macgregor Hydrostatic delivery system for controlled delivery of agent
US8007826B2 (en) 2003-12-11 2011-08-30 Acorda Therapeutics, Inc. Sustained release aminopyridine composition
US8354437B2 (en) 2004-04-09 2013-01-15 Acorda Therapeutics, Inc. Method of using sustained release aminopyridine compositions
AU2005301046B2 (en) 2004-11-02 2012-02-23 Chr. Hansen A/S Stabilized bacteriophage formulations
US10377708B2 (en) 2017-12-05 2019-08-13 Sunovion Pharmaceuticals Inc. Crystal forms and production methods thereof
CN118593482A (zh) 2017-12-05 2024-09-06 赛诺维信制药公司 非外消旋混合物及其用途
JP2022535893A (ja) 2019-06-04 2022-08-10 サノビオン ファーマシューティカルズ インク 放出調節製剤およびその使用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2793979A (en) * 1953-03-30 1957-05-28 Smith Kline French Lab Method of making a sustained release pharmaceutical tablet and product of the method
US2805977A (en) * 1955-01-04 1957-09-10 Smith Kline French Lab Sustained release pharmaceutical preparation
US2875130A (en) * 1956-11-20 1959-02-24 Smith Kline French Lab Method of preparing sustained release particles and the product of the method
GB906422A (en) * 1958-05-02 1962-09-19 Wellcome Found Improvements in and relating to prolonged acting pharmaceutical preparations
US3065143A (en) * 1960-04-19 1962-11-20 Richardson Merrell Inc Sustained release tablet
NL265428A (de) * 1960-06-06
US3346449A (en) * 1963-09-27 1967-10-10 Hoffmann La Roche d-methorphan compositions and methods of making same

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0095123A3 (en) * 1982-05-20 1984-12-12 Merrell Dow Pharmaceuticals Inc. Sustained release diethylpropion compositions
EP0120118A1 (de) * 1983-01-03 1984-10-03 Verex Laboratories, Inc. Feste orale Dosierungsformulierungen von kardiovaskularen Heilmitteln mit konstanter Freisetzungsgeschwindigkeit

Also Published As

Publication number Publication date
FR4892M (de) 1967-03-06
BR6572781D0 (pt) 1973-08-02
GB1112332A (en) 1968-05-01
DE1492253A1 (de) 1969-12-18
US3459850A (en) 1969-08-05
CH415963A (de) 1966-06-30

Similar Documents

Publication Publication Date Title
CH498825A (de) Verfahren zur Herstellung von 2-C-Methyl-nukleosiden
AT306765B (de) Verfahren zur Herstellung von Ferrovanadin
AT273041B (de) Verfahren zur Herstellung von festen Lösungen
AT264715B (de) Verfahren zur Herstellung von Tabletten mit protrahierter Wirkung
CH507326A (de) Verfahren zur Herstellung von Poly-e-caproamid
AT251884B (de) Verfahren zur Herstellung von transparenten Polykondensaten
CH454163A (de) Verfahren zur Herstellung von Polyhalogenphenolen
CH479636A (de) Verfahren zur Herstellung von Copolymerisaten
CH473192A (de) Verfahren zur Herstellung von basischen Farbstoffen
CH469785A (de) Verfahren zur Herstellung von basischen Farbstoffen
CH466265A (de) Verfahren zur Herstellung von Thioformamid
AT256808B (de) Verfahren zur Herstellung von ɛ-Caprolactam
AT260539B (de) Verfahren zur Herstellung von Schwefel-Harz-Massen
CH459580A (de) Verfahren zur Herstellung von Polymerisaten
AT270199B (de) Verfahren zur Herstellung von amorphen Copolymerisaten
CH451113A (de) Verfahren zur Herstellung von substituierten Guanidinen
CH487950A (de) Kontinuierliches Verfahren zur Herstellung von länglichen Gegenständen
CH473129A (de) Verfahren zur Herstellung von Sulfanilamido-Chinazolinen
CH502970A (de) Verfahren zur Herstellung von Methylen-d2-chlorid
AT255124B (de) Verfahren zur Herstellung von Mischpolymerisaten
CH479530A (de) Verfahren zur Herstellung von Mononitrocyclohexan
CH458325A (de) Verfahren zur Herstellung von Dicyanacetylen
CH440553A (de) Verfahren zur Herstellung von Zedalan
CH473801A (de) Verfahren zur Herstellung von 4-Alkyl-prolinen
CH490295A (de) Verfahren zur Herstellung von Fluorchlormethanen